From: Effects of plasma-activated Ringer’s lactate solution on cancer cells: evaluation of genotoxicity
Treatment a), b) | H2O2 Concentration (μM) | Mutation Frequency (10−7) | Relative Mutation frequency |
---|---|---|---|
Lactec | N.D.c) | 10.4 ± 0.7 | 1.00 |
16-fold diluted 5-min PAL | 65.3 | 161.2 ± 9.4 | 15.50 |
32-fold diluted 10-min PAL | 42.7 | 56.6 ± 1.9 | 5.44 |
5-min PAL with catalase | N.D.c) | 9.2 ± 0.9 | 0.88 |
1.5-fold diluted 10-min PAL with catalase | N.D.c) | 10.8 ± 1.3 | 1.04 |